Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros










Tipo de estudo
Intervalo de ano de publicação
1.
Endocrinol. diabetes nutr. (Ed. impr.) ; 66(1): 62-68, ene. 2019. graf
Artigo em Espanhol | IBECS | ID: ibc-175795

RESUMO

La importante prevalencia y morbimortalidad de la obesidad ha ocasionado un aumento de pacientes sometidos a cirugía bariátrica. Son numerosos los beneficios reportados de la cirugía de la obesidad en distintas esferas de la salud. Sin embargo, no ocurre lo mismo sobre el hueso, donde tiene un impacto negativo. Los mecanismos fisiopatológicos que subyacen en el deterioro del tejido óseo de estos pacientes son complejos y requieren de un estudio en profundidad. El adecuado conocimiento de estos factores permitirá adoptar las herramientas más oportunas para un adecuado abordaje terapéutico


The important prevalence and morbidity of obesity has generated an increase in bariatric surgery. It has a positive effect in obesity-related comorbidities. However, it's detrimental to bone health. The underline pathophysiological mechanisms are complex and heterogeneous. The knowledge of these factors may lead us to develop an adequate therapeutic intervention


Assuntos
Humanos , Cirurgia Bariátrica/métodos , Osso e Ossos/fisiopatologia , Obesidade/cirurgia , Cirurgia Bariátrica , Cirurgia Bariátrica/efeitos adversos , Obesidade/epidemiologia , Obesidade/complicações , Fraturas Ósseas , Suplementos Nutricionais , Terapia Combinada/métodos , Densitometria , Osteoporose/tratamento farmacológico
2.
Endocrinol Diabetes Nutr ; 66(1): 62-68, 2019 Jan.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-30266592

RESUMO

The important prevalence and morbidity of obesity has generated an increase in bariatric surgery. It has a positive effect in obesity-related comorbidities. However, it's detrimental to bone health. The underline pathophysiological mechanisms are complex and heterogeneous. The knowledge of these factors may lead us to develop an adequate therapeutic intervention.


Assuntos
Cirurgia Bariátrica/efeitos adversos , Doenças Ósseas/etiologia , Complicações Pós-Operatórias/etiologia , Doenças Ósseas/fisiopatologia , Doenças Ósseas/terapia , Humanos , Complicações Pós-Operatórias/fisiopatologia , Complicações Pós-Operatórias/terapia
3.
Endocrinol. nutr. (Ed. impr.) ; 63(3): 132-138, mar. 2016. tab
Artigo em Espanhol | IBECS | ID: ibc-150559

RESUMO

En los últimos años está creciendo el interés en la dieta pobre en fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) como pilar importante en el tratamiento del síndrome de intestino irritable (SII). Este modelo de dieta lo desarrolló un equipo multidisciplinar de la Universidad de Monash, en Melbourne, y empezó a ganar notoriedad a partir de la publicación de un estudio en 2008 que demostraba que los hidratos de carbono fermentables (FODMAPs) de la dieta actuaban como causantes de síntomas en los pacientes con SII. Desde entonces se han llevado a cabo varios ensayos controlados aleatorizados que, aunque con muestras reducidas de pacientes, han vuelto a demostrar las ventajas de este modelo dietético (AU)


In recent years, there has been growing interest in diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) as an important mainstay in the treatment of irritable bowel syndrome (IBS). This model of diet was developed by a multidisciplinary team from the Monash University in Melbourne and became well-known after the publication of a study in 2008 showing that dietary FODMAPs acted as causing factors in patients with IBS. Since then there have been several randomized controlled trials which, although with small sample sizes, have again shown the benefits of this dietary pattern (AU)


Assuntos
Humanos , Síndrome do Intestino Irritável/dietoterapia , Terapia Nutricional/métodos , Carboidratos da Dieta/análise , Glutens/efeitos adversos , Intolerância à Lactose/dietoterapia , Intolerância à Frutose/dietoterapia
4.
Endocrinol Nutr ; 63(3): 132-8, 2016 Mar.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-26830853

RESUMO

In recent years, there has been growing interest in diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) as an important mainstay in the treatment of irritable bowel syndrome (IBS). This model of diet was developed by a multidisciplinary team from the Monash University in Melbourne and became well-known after the publication of a study in 2008 showing that dietary FODMAPs acted as causing factors in patients with IBS. Since then there have been several randomized controlled trials which, although with small sample sizes, have again shown the benefits of this dietary pattern.


Assuntos
Dissacarídeos , Síndrome do Intestino Irritável/dietoterapia , Monossacarídeos , Oligossacarídeos , Dieta , Fermentação , Humanos
5.
Endocrinol. nutr. (Ed. impr.) ; 62(6): 285-1289, jun.-jul. 2015. tab
Artigo em Espanhol | IBECS | ID: ibc-140172

RESUMO

La afectación de la función hepática asociada con la nutrición parenteral es un problema especialmente importante en los pacientes que precisan este tipo de soporte nutricional durante un tiempo prolongado. La prevalencia es muy variable según las series, y se presenta clínicamente de forma distinta en adultos y en niños. Su etiología no está bien definida y se contempla la participación de varios factores al mismo tiempo. Cuando se detecta un nivel de bilirrubina > 2 mg/dl durante un período prolongado se deben descartar otras causas de hepatopatía y minimizar los factores de riesgo. La composición de las emulsiones lipídicas empleadas en la nutrición parenteral es uno de los factores relacionados con la alteración de la función hepática. En este artículo se revisan los distintos tipos de emulsiones lipídicas, así como los posibles beneficios de las fórmulas enriquecidas con ácidos grasos omega-3 (AU)


Parenteral nutrition-associated liver disease (PNALD) is a particularly important problem in patients who need this type of nutritional support for a long time. Prevalence of the condition is highly variable depending on the series, and its clinical presentation is different in adults and children. The etiology of PNALD is not well defined, and participation of several factors at the same time has been suggested. When a bilirubin level >2 mg/dl is detected for a long time, other causes of liver disease should be ruled out and risk factors should be minimized. The composition of lipid emulsions used in parenteral nutrition is one of the factors related to PNALD. This article reviews the different types of lipid emulsions and the potential benefits of emulsions enriched with omega-3 fatty acids (AU)


Assuntos
Feminino , Humanos , Masculino , Hepatopatias/complicações , Hepatopatias/patologia , Hepatopatias/terapia , Nutrição Parenteral/efeitos adversos , Nutrição Parenteral , Hepatopatias/diagnóstico , Ácidos Graxos/administração & dosagem , Óleo de Soja/administração & dosagem , Óleo de Soja/metabolismo , Óleo de Palmeira/prevenção & controle , Hipertensão Portal/patologia , Hipertensão Portal/prevenção & controle
7.
Endocrinol Nutr ; 62(6): 285-9, 2015.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-25982234

RESUMO

Parenteral nutrition-associated liver disease (PNALD) is a particularly important problem in patients who need this type of nutritional support for a long time. Prevalence of the condition is highly variable depending on the series, and its clinical presentation is different in adults and children. The etiology of PNALD is not well defined, and participation of several factors at the same time has been suggested. When a bilirubin level >2 mg/dl is detected for a long time, other causes of liver disease should be ruled out and risk factors should be minimized. The composition of lipid emulsions used in parenteral nutrition is one of the factors related to PNALD. This article reviews the different types of lipid emulsions and the potential benefits of emulsions enriched with omega-3 fatty acids.


Assuntos
Emulsões Gordurosas Intravenosas/efeitos adversos , Hepatopatias/etiologia , Nutrição Parenteral/efeitos adversos , Emulsões Gordurosas Intravenosas/classificação , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA